A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder

NCT00892125 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Bipolar Disorder

Interventions

DRUG: paliperidone ER; Carbamazepine

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.